ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

Severe obesity in a patient on long-term treatment of chronic myeloid leukemia with imatinib: Body composition, associated disorders and outcome

Journal: Journal of Clinical Images and Medical Case Reports (Vol.2, No. 6)

Publication Date:

Authors : ; ; ; ; ;

Page : 1-3

Keywords : chronic myeloid leukemia; obesity; imatinib; sleep apnea hypopnea syndrome.;

Source : Downloadexternal Find it from : Google Scholarexternal


Chronic Myeloid Leukemia (CML) is a highly curable malignancy with tyrosine kinase inhibitors (TKI) as target therapy. As treatment is usually prolonged, there is a need to improve our knowledge about the impact of comorbidities in this context. Severe obesity is among the common comorbidities in these patients. We present the case of a patient with morbid obesity and associated sleep apnea hypopnea syndrome who was succesfully treated during 14 years with imatinib, a cornerstone TKI for this disease. Visceral fat area was extremely elevated in this patient.

Last modified: 2021-12-13 11:35:22